Fri, May 6, 2022
Thu, May 5, 2022
Wed, May 4, 2022

Charles Zhu Upgraded (ZYME) to Strong Buy and Held Target at $14 on, May 5th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-14-on-may-5th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Zhu of Guggenheim, Upgraded "Zymeworks Inc." (ZYME) to Strong Buy and Held Target at $14 on, May 5th, 2022.

Charles has made no other calls on ZYME in the last 4 months.



There are 3 other peers that have a rating on ZYME. Out of the 3 peers that are also analyzing ZYME, 0 agree with Charles's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Charles


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $15 on, Tuesday, March 15th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Monday, February 28th, 2022
  • Jim Birchenough of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Wednesday, February 9th, 2022

Publication Contributing Sources